Chih-Feng Chian Selected Research

Therapeutics

1/2021	Association Between Statin Use and Exacerbation of Chronic Obstructive Pulmonary Disease Among Patients Receiving Corticosteroids.
1/2019	Factors associated with improvement in symptoms and quality of life for first-line EGFR-tyrosine kinase inhibitor treatment in patients with EGFR-mutated non-small-cell lung cancer - A multicenter prospective SMILE study.
4/2015	Intravenous immunoglobulin replacement therapy to prevent pulmonary infection in a patient with Good's syndrome.
8/2012	Platelet-lowering therapy with anagrelide as an adjuvant therapy for treatment of primary pulmonary neoplasm-associated extreme thrombocytosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Chih-Feng Chian Research Topics

Disease

9	Neoplasms (Cancer) 01/2022 - 07/2009
5	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 09/2015
5	Lung Injury 01/2017 - 08/2012
3	Chronic Obstructive Pulmonary Disease (COPD) 01/2021 - 01/2011
3	Lung Neoplasms (Lung Cancer) 07/2020 - 01/2012
3	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2016 - 11/2009
2	Wounds and Injuries (Trauma) 01/2022 - 06/2013
2	Neoplasm Metastasis (Metastasis) 01/2022 - 01/2012
2	Weight Gain 01/2016 - 08/2012
2	Asthma (Bronchial Asthma) 04/2011 - 12/2010
1	Malignant Pleural Effusion 01/2022
1	Pleural Effusion (Pleural Effusions) 01/2022
1	Myositis (Idiopathic Inflammatory Myopathies) 07/2017
1	Carcinoma (Carcinomatosis) 07/2017
1	Renal Cell Carcinoma (Grawitz Tumor) 07/2017
1	Melanoma (Melanoma, Malignant) 07/2017
1	Myasthenia Gravis 07/2017
1	Respiratory Insufficiency (Respiratory Failure) 07/2017
1	Pulmonary Edema 01/2017
1	Inflammation (Inflammations) 01/2016
1	Tuberculosis (Tuberculoses) 06/2015
1	Latent Tuberculosis 06/2015
1	Infections 04/2015
1	Thymoma (Thymic Carcinoma) 04/2015
1	Pneumonia (Pneumonitis) 04/2015
1	Cytomegalovirus Infections (Inclusion Disease) 04/2015
1	Gastroesophageal Reflux (GERD) 03/2015
1	Liver Cirrhosis (Hepatic Cirrhosis) 09/2014
1	Extranodal NK-T-Cell Lymphoma 01/2014
1	Peritonitis 06/2013
1	Hypotension (Low Blood Pressure) 06/2013
1	Acidosis 06/2013
1	Sepsis (Septicemia) 06/2013
1	Necrosis 08/2012
1	Ventilator-Induced Lung Injury 08/2012
1	Thrombocytosis (Thrombocythemia) 08/2012
1	Multiple Pulmonary Nodules 01/2012
1	Invasive Pulmonary Aspergillosis 01/2012
1	Mannose-Binding Protein Deficiency 01/2011
1	Respiratory Tract Infections (Respiratory Tract Infection) 01/2011

Drug/Important Bio-Agent (IBA)

3	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2021 - 01/2010
3	CytokinesIBA 01/2017 - 08/2012
3	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2017 - 08/2012
2	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2022 - 06/2013
2	Peptides (Polypeptides)IBA 01/2016 - 03/2014
2	Peroxidase (Myeloperoxidase)IBA 01/2016 - 08/2012
2	Ethiodized Oil (Ethiodol)FDA Link 09/2014 - 11/2009
2	LipopolysaccharidesIBA 03/2014 - 08/2012
2	AlbuminsIBA 06/2013 - 08/2012
2	Adrenocorticotropic Hormone (ACTH)FDA Link 01/2012 - 07/2009
1	Saline SolutionIBA 01/2022
1	Carcinoembryonic AntigenIBA 01/2022
1	pembrolizumabIBA 01/2022
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2021
1	tepotinibIBA 11/2020
1	Gefitinib (Iressa)FDA Link 11/2020
1	ErbB Receptors (EGF Receptor)IBA 11/2020
1	hydrogen sulfite (bisulfite)IBA 07/2020
1	Decitabine FDA Link 07/2020
1	Tyrosine Kinase InhibitorsIBA 01/2019
1	Cyclin D1IBA 01/2018
1	NivolumabIBA 07/2017
1	Immune Checkpoint InhibitorsIBA 07/2017
1	AutoantibodiesIBA 07/2017
1	EnzymesIBA 07/2017
1	Cytochromes c (Cytochrome c)IBA 01/2017
1	AntioxidantsIBA 01/2017
1	RNA (Ribonucleic Acid)IBA 08/2016
1	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 01/2016
1	InterleukinsIBA 01/2016
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2016
1	GoldIBA 06/2015
1	Intravenous Immunoglobulins (IVIG)FDA Link 04/2015
1	Doxorubicin (Adriamycin)FDA LinkGeneric 09/2014
1	Serum AlbuminIBA 09/2014
1	DNA (Deoxyribonucleic Acid)IBA 01/2014
1	NitrogenIBA 06/2013
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 06/2013
1	Urea (Carbamide)FDA LinkGeneric 06/2013
1	hyperoncotic albuminIBA 06/2013
1	Acetylcysteine (Siran)FDA LinkGeneric 08/2012
1	Caspase 3 (Caspase-3)IBA 08/2012
1	anagrelide (Agrylin)FDA LinkGeneric 08/2012
1	acetovanillone (apocynin)IBA 08/2012
1	Prednisolone (Predate)FDA LinkGeneric 04/2011
1	SuspensionsIBA 04/2011
1	Budesonide (Pulmicort)FDA LinkGeneric 04/2011
1	Mannose-Binding Lectin (Mannan-Binding Lectin)IBA 01/2011
1	CarcinogensIBA 05/2010

Therapy/Procedure

4	Therapeutics 01/2021 - 08/2012
3	Drug Therapy (Chemotherapy) 01/2022 - 07/2009
2	Mechanical Ventilators (Ventilator) 07/2017 - 03/2015
2	Artificial Respiration (Mechanical Ventilation) 03/2015 - 08/2012
1	Radiotherapy 01/2022
1	Adjuvant Chemotherapy 09/2015
1	Thymectomy 04/2015
1	Ligation 06/2013
1	Punctures 06/2013
1	Ambulatory Care (Outpatient Care) 12/2010
1	Extracorporeal Membrane Oxygenation 01/2010